COMBINATION THERAPY FOR TREATING CANCER

The disclosure relates to combinations comprising inhibitors of human histone methyltransferase DOT1L and one or more therapeutic agents, particularly anticancer agents, and methods of combination therapy for administering to subjects in need thereof for the treatment of cancer.

Saved in:

Bibliographic Details
Main Authors	RAIMONDI, Maria Alejandra, CHOPRA, Vivek, POLLOCK, Roy MacFarlane, KLAUS, Christine, DAIGLE, Scott Richard
Format	Patent
Language	English
Published	30.01.2020
Subjects	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online Access	Get full text

Cover

More Information
Summary:	The disclosure relates to combinations comprising inhibitors of human histone methyltransferase DOT1L and one or more therapeutic agents, particularly anticancer agents, and methods of combination therapy for administering to subjects in need thereof for the treatment of cancer.
Bibliography:	Application Number: US201916248925